See more : Sanlam Limited (SLMAF) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Beeyu Overseas Limited (BEEYU.BO) Income Statement Analysis – Financial Results
- Pharma Equity Group A/S (PEG-A.CO) Income Statement Analysis – Financial Results
- Cayson Acquisition Corp Ordinary shares (CAPN) Income Statement Analysis – Financial Results
- Aurora Investment Trust plc (ARR.L) Income Statement Analysis – Financial Results
- CSR Limited (CSRLF) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
| Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
| Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
| Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
| Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
| Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
| Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
| Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
| Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
| Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
| EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
| EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
| Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
| Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
| Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
| Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
| Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
| Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
| Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
| Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
| EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
| Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
Sotera Health Announces First-Quarter 2024 Earnings Release Date
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
Source: https://incomestatements.info
Category: Stock Reports